Kedalion Therapeutics
Kedalion Therapeutics is a biotechnology company that develops and commercializes transformative topical ophthalmic therapies for both new and existing indications. When compared to standard eye drops, Kedalion's proprietary AcuStream platform technology delivers topical drugs to the eye in a precise and accurate manner, enabling comparable effects with up to an 80% reduction in dose. AcuStream is a novel, digitally connected, electromechanical topical ocular delivery device that aims to fill a potential unmet need for a convenient, user-friendly device that reliably, accurately, and comfortably delivers topical ocular therapy with increased efficiency and patient comfort.
Industries
Nr. of Employees
small (1-50)
Kedalion Therapeutics
Menlo Park, California, United States, North America
Products
AcuStream
A preservative-free, electromechanical topical ocular delivery device designed to facilitate precise dosing and accurate delivery of certain topical ophthalmic medications.
Xiidra
A prescription LFA-1 antagonist indicated for the treatment of signs and symptoms of dry eye disease.
AcuStream
A preservative-free, electromechanical topical ocular delivery device designed to facilitate precise dosing and accurate delivery of certain topical ophthalmic medications.
Xiidra
A prescription LFA-1 antagonist indicated for the treatment of signs and symptoms of dry eye disease.